Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38808502/
With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood. Chronic heart failure is increasingly being recognized as a major...
Chronic heart failure in children with congenital heart disease requires better understanding of its epidemiology, pathophysiology, and outcomes to develop evidence-based therapies and improve management strategies for this high-risk population.
Share
Semaglutide significantly improved heart failure symptoms, physical limitations, body weight, exercise function, and reduced CRP levels in obesity-related HFpEF patients, with consistent benefits across subgroups and fewer serious adverse events.
Share
Beta-blocker therapy in heart failure with preserved ejection fraction (B-HFpEF): A systematic review and meta-analysis - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38184132/
This meta-analysis showed that beta-blocker therapy has the potential to reduce all-cause mortality in patients with HFpEF based on observational studies. Nevertheless, it did not affect rehospitalization for heart failure...
Beta-blockers may reduce all-cause mortality in HFpEF patients but show no impact on heart failure rehospitalization. Large-scale randomized trials are needed to confirm their efficacy in this population.
Share
Treating iron deficiency in patients with heart failure: what, why, when, how, where and who - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/39160066/
For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an...
Iron deficiency in heart failure worsens outcomes but improves with intravenous iron therapy. Current diagnostic criteria are flawed; targeting transferrin saturation <20% may enhance treatment response and patient care.
Share
Diagnosis and management of cancer therapy-related myocarditis in a young female: A case report and review of literature - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/38858610/
In this case, based on negative tests and the absence of viral signs and symptoms, Cancer therapy-related myocarditis is highly suspected as the cause of myocarditis. This case underscores the...
A 19-year-old with ES/PNET treated with VAC/IE developed chemotherapy-related myocarditis. Diagnosed via CMR, she responded significantly to IVIG, improving LVEF, highlighting its potential for treating reversible myocarditis.
Share